{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:34:35Z","timestamp":1793410475828,"version":"4.5.0"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04747-8","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:02:54Z","timestamp":1781794974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoparticles that target nonamyloid and nontau pathways in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Firoozeh","family":"Alavian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh","family":"Hajimohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"1","key":"4747_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, et al. Alzheimer disease. Nat Rev Dis Prim. 2021;7(1):33.","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"4747_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11064-018-2603-y","volume":"44","author":"BW Menta","year":"2019","unstructured":"Menta BW, Swerdlow RH. An integrative overview of non-amyloid and non-tau pathologies in Alzheimer\u2019s disease. Neurochem Res. 2019;44(1):12\u201321.","journal-title":"Neurochem Res"},{"key":"4747_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117253","volume":"421","author":"V Bhatia","year":"2021","unstructured":"Bhatia V, Sharma S. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease. J Neurol Sci. 2021;421:117253.","journal-title":"J Neurol Sci"},{"issue":"14","key":"4747_CR4","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.3390\/jcm13144130","volume":"13","author":"E Caradonna","year":"2024","unstructured":"Caradonna E, et al. The brain\u2013gut axis, an important player in Alzheimer and Parkinson disease: a narrative review. J Clin Med. 2024;13(14):4130.","journal-title":"J Clin Med"},{"issue":"7","key":"4747_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276\u201390.","journal-title":"Cell"},{"issue":"8","key":"4747_CR6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","volume":"1842","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH, Burns JM, Khan SM. The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta. 2014;1842(8):1219\u201331.","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"4747_CR7","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.3390\/molecules25225294","volume":"25","author":"Y Zorkina","year":"2020","unstructured":"Zorkina Y, et al. Nano carrier drug delivery systems for the treatment of neuropsychiatric disorders: advantages and limitations. Molecules. 2020;25(22):5294.","journal-title":"Molecules"},{"issue":"3","key":"4747_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/pharmaceutics17030388","volume":"17","author":"Y Zou","year":"2025","unstructured":"Zou Y, et al. Targeting neuroinflammation in central nervous system diseases by oral delivery of lipid nanoparticles. Pharmaceutics. 2025;17(3):388.","journal-title":"Pharmaceutics"},{"key":"4747_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102669","author":"X Hong","year":"2025","unstructured":"Hong X, et al. Design, current states, and challenges of nanomaterials in anti-neuroinflammation: a perspective on Alzheimer\u2019s disease. Ageing Res Rev. 2025. https:\/\/doi.org\/10.1016\/j.arr.2025.102669.","journal-title":"Ageing Res Rev"},{"issue":"43","key":"4747_CR10","doi-asserted-by":"publisher","first-page":"1701921","DOI":"10.1002\/smll.201701921","volume":"13","author":"YH Tsou","year":"2017","unstructured":"Tsou YH, et al. Drug delivery to the brain across the blood\u2013brain barrier using nanomaterials. Small. 2017;13(43):1701921.","journal-title":"Small"},{"issue":"3","key":"4747_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1049\/nbt2.12127","volume":"17","author":"C Jalili","year":"2023","unstructured":"Jalili C, et al. Brain targeting based nanocarriers loaded with resveratrol in Alzheimer\u2019s disease: A review. IET Nanobiotechnol. 2023;17(3):154\u201370.","journal-title":"IET Nanobiotechnol"},{"key":"4747_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"VP Menon","year":"2007","unstructured":"Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105\u201325.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"4747_CR13","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","volume":"13","author":"MK Satapathy","year":"2021","unstructured":"Satapathy MK, et al. Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics. 2021;13(8):1183.","journal-title":"Pharmaceutics"},{"issue":"2","key":"4747_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/antiox11020408","volume":"11","author":"A Ashok","year":"2022","unstructured":"Ashok A, et al. Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation. Antioxidants. 2022;11(2):408.","journal-title":"Antioxidants"},{"issue":"2","key":"4747_CR15","first-page":"105","volume":"6","author":"E Mohammadi","year":"2021","unstructured":"Mohammadi E, et al. An overview of antimicrobial efficacy of curcumin-silver nanoparticles. Nanomed Res J. 2021;6(2):105\u201311.","journal-title":"Nanomed Res J"},{"key":"4747_CR16","doi-asserted-by":"publisher","first-page":"1563701","DOI":"10.3389\/fbioe.2025.1563701","volume":"13","author":"AC Buck","year":"2025","unstructured":"Buck AC, et al. Mitochondria targeted nanoparticles for the treatment of mitochondrial dysfunction-associated brain disorders. Front Bioeng Biotechnol. 2025;13:1563701.","journal-title":"Front Bioeng Biotechnol"},{"key":"4747_CR17","volume":"7","author":"S Chowdhury","year":"2025","unstructured":"Chowdhury S, Kumari G, Jit T. Nano-formulation of phytochemicals to combat neurodegenerative diseases: Current and thorough strategies. Pharmacol Res Nat Prod. 2025;7:100249.","journal-title":"Pharmacol Res Nat Prod"},{"issue":"4","key":"4747_CR18","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","volume":"18","author":"T Lei","year":"2024","unstructured":"Lei T, et al. Mannose-integrated nanoparticle hitchhike glucose transporter 1 Recycling to overcome various barriers of oral delivery for Alzheimer\u2019s disease therapy. ACS Nano. 2024;18(4):3234\u201350.","journal-title":"ACS Nano"},{"key":"4747_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101457","volume":"44","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. Regulation of neuroinflammation with GLP-1 receptor targeting nanostructures to alleviate Alzheimer\u2019s symptoms in the disease models. Nano Today. 2022;44:101457.","journal-title":"Nano Today"},{"issue":"4","key":"4747_CR20","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.apsb.2022.02.001","volume":"12","author":"X He","year":"2022","unstructured":"He X, et al. Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer\u2019s disease treatment by anti-neuroinflammation and neuroprotection. Acta Pharm Sin B. 2022;12(4):1987\u201399.","journal-title":"Acta Pharm Sin B"},{"key":"4747_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120714","volume":"310","author":"L Yang","year":"2023","unstructured":"Yang L, et al. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease. Carbohydr Polym. 2023;310:120714.","journal-title":"Carbohydr Polym"},{"key":"4747_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202418560","author":"Y Pu","year":"2025","unstructured":"Pu Y, et al. Hybrid lipoplex boosts neuron\u2010microglia crosstalk for treatment of alzheimer\u2019s disease through A\u03b2\u2010targeted\u2010autophagy and ApoE2 gene supplementation. Adv Mater. 2025. https:\/\/doi.org\/10.1002\/adma.202418560.","journal-title":"Adv Mater"},{"issue":"8","key":"4747_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309225","volume":"36","author":"WT Ralvenius","year":"2024","unstructured":"Ralvenius WT, et al. Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation. Adv Mater. 2024;36(8):e2309225.","journal-title":"Adv Mater"},{"issue":"7","key":"4747_CR24","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.sjbs.2020.04.045","volume":"27","author":"MS Almuhayawi","year":"2020","unstructured":"Almuhayawi MS, et al. The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model. Saudi J Biol Sci. 2020;27(7):1710\u20136.","journal-title":"Saudi J Biol Sci"},{"issue":"42","key":"4747_CR25","doi-asserted-by":"publisher","first-page":"49602","DOI":"10.1021\/acsami.1c06687","volume":"13","author":"Z Jia","year":"2021","unstructured":"Jia Z, et al. A functionalized octahedral palladium nanozyme as a radical scavenger for ameliorating Alzheimer\u2019s disease. ACS Appl Mater Interfaces. 2021;13(42):49602\u201313.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"4747_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alzheimer\u2019s disease. Biomedical Reports. 2016;4(5):519\u201322.","journal-title":"Biomedical Reports"},{"key":"4747_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105050","volume":"148","author":"P Sch\u00f6nfeld","year":"2021","unstructured":"Sch\u00f6nfeld P, Reiser G. How the brain fights fatty acids\u2019 toxicity. Neurochem Int. 2021;148:105050.","journal-title":"Neurochem Int"},{"issue":"8","key":"4747_CR28","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, et al. Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis. 2014;1842(8):1240\u20137.","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Basis Dis"},{"issue":"1","key":"4747_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):124.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4747_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/10715762.2011.648188","volume":"46","author":"RX Santos","year":"2012","unstructured":"Santos RX, et al. Nuclear and mitochondrial DNA oxidation in Alzheimer\u2019s disease. Free Radic Res. 2012;46(4):565\u201376.","journal-title":"Free Radic Res"},{"issue":"4","key":"4747_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1212\/WNL.49.4.918","volume":"49","author":"RH Swerdlow","year":"1997","unstructured":"Swerdlow RH, et al. Cybrids in Alzheimer\u2019s disease: a cellular model of the disease? Neurology. 1997;49(4):918\u201325.","journal-title":"Neurology"},{"key":"4747_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2022.05.025","volume":"187","author":"MC Chiang","year":"2022","unstructured":"Chiang MC, Nicol CJB. GSH-AuNP anti-oxidative stress, ER stress and mitochondrial dysfunction in amyloid-beta peptide-treated human neural stem cells. Free Radic Biol Med. 2022;187:185\u2013201.","journal-title":"Free Radic Biol Med"},{"key":"4747_CR33","volume":"3","author":"TA Tabish","year":"2021","unstructured":"Tabish TA, Hamblin MR. Mitochondria-targeted nanoparticles (mitoNANO): an emerging therapeutic shortcut for cancer. Biomater Biosyst. 2021;3:100023.","journal-title":"Biomater Biosyst"},{"issue":"1","key":"4747_CR34","first-page":"51","volume":"9","author":"N Oh","year":"2014","unstructured":"Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomed. 2014;9(1):51\u201363.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4747_CR35","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","volume":"10","author":"HJ Kwon","year":"2016","unstructured":"Kwon HJ, et al. Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease. ACS Nano. 2016;10(2):2860\u201370.","journal-title":"ACS Nano"},{"issue":"20","key":"4747_CR36","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.7150\/thno.29039","volume":"8","author":"A Sharma","year":"2018","unstructured":"Sharma A, et al. Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics. Theranostics. 2018;8(20):5529\u201347.","journal-title":"Theranostics"},{"key":"4747_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","volume":"108","author":"C Gao","year":"2020","unstructured":"Gao C, et al. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice. Acta Biomater. 2020;108:285\u201399.","journal-title":"Acta Biomater"},{"issue":"1","key":"4747_CR38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","volume":"27","author":"Y Han","year":"2020","unstructured":"Han Y, et al. Neuronal mitochondria-targeted therapy for Alzheimer\u2019s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Drug Delivery. 2020;27(1):502\u201318.","journal-title":"Drug Delivery"},{"issue":"10","key":"4747_CR39","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.1021\/acsnano.0c09553","volume":"15","author":"B Surnar","year":"2021","unstructured":"Surnar B, et al. Brain-accumulating nanoparticles for assisting astrocytes to reduce human immunodeficiency virus and drug abuse-induced neuroinflammation and oxidative stress. ACS Nano. 2021;15(10):15741\u201353.","journal-title":"ACS Nano"},{"issue":"19","key":"4747_CR40","doi-asserted-by":"publisher","first-page":"22977","DOI":"10.1021\/acsami.3c03181","volume":"15","author":"W Li","year":"2023","unstructured":"Li W, et al. Multifunctional DNA tetrahedron for Alzheimer\u2019s disease mitochondria-targeted therapy by MicroRNA regulation. ACS Appl Mater Interfaces. 2023;15(19):22977\u201384.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"22","key":"4747_CR41","doi-asserted-by":"publisher","first-page":"2300758","DOI":"10.1002\/advs.202300758","volume":"10","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, et al. Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson\u2019s disease. Adv Sci. 2023;10(22):2300758.","journal-title":"Adv Sci"},{"issue":"6","key":"4747_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.37349\/ebmx.2024.00024","volume":"1","author":"H Aslam","year":"2024","unstructured":"Aslam H, et al. Nanomaterials in the treatment of degenerative intellectual and developmental disabilities. Explor BioMat-X. 2024;1(6):353\u201365.","journal-title":"Explor BioMat-X"},{"key":"4747_CR43","doi-asserted-by":"crossref","unstructured":"Zhang, Y., et al. Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases. In: Exploration. 2021. Wiley Online Library.","DOI":"10.1002\/EXP.20210115"},{"issue":"2021","key":"4747_CR44","volume":"3","author":"T Tabish","year":"2021","unstructured":"Tabish T, Hamblin M. Mitochondria-targeted nanoparticles (mitoNANO): an emerging therapeutic shortcut for cancer. Biomater Biosyst. 2021;3(2021):100023.","journal-title":"Biomater Biosyst"},{"key":"4747_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123142","volume":"318","author":"E Park","year":"2025","unstructured":"Park E, et al. Brain microenvironment-remodeling nanomedicine improves cerebral glucose metabolism, mitochondrial activity and synaptic function in a mouse model of Alzheimer\u2019s disease. Biomaterials. 2025;318:123142.","journal-title":"Biomaterials"},{"issue":"7","key":"4747_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204596","volume":"10","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. Nano-brake halts mitochondrial dysfunction cascade to alleviate neuropathology and rescue Alzheimer\u2019s cognitive deficits. Adv Sci (Weinh). 2023;10(7):e2204596.","journal-title":"Adv Sci (Weinh)"},{"key":"4747_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119752","volume":"232","author":"C Ren","year":"2020","unstructured":"Ren C, et al. Mitochondria-targeted TPP-MoS(2) with dual enzyme activity provides efficient neuroprotection through M1\/M2 microglial polarization in an Alzheimer\u2019s disease model. Biomaterials. 2020;232:119752.","journal-title":"Biomaterials"},{"issue":"17","key":"4747_CR48","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.3390\/ijms25179690","volume":"25","author":"A Dey","year":"2024","unstructured":"Dey A, et al. Alzheimer\u2019s disease pathology and assistive nanotheranostic approaches for its therapeutic interventions. Int J Mol Sci. 2024;25(17):9690.","journal-title":"Int J Mol Sci"},{"key":"4747_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejpb.2023.01.006","volume":"184","author":"M Samir","year":"2023","unstructured":"Samir M, et al. Enhancement of mitochondrial function using NO releasing nanoparticles; a potential approach for therapy of Alzheimer\u2019s disease. Eur J Pharm Biopharm. 2023;184:16\u201324.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"4747_CR50","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s12640-021-00362-w","volume":"39","author":"OV Ramires J\u00fanior","year":"2021","unstructured":"Ramires J\u00fanior OV, et al. Nanoemulsion improves the neuroprotective effects of curcumin in an experimental model of Parkinson\u2019s disease. Neurotox Res. 2021;39(3):787\u201399.","journal-title":"Neurotox Res"},{"issue":"12","key":"4747_CR51","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/acschemneuro.6b00207","volume":"7","author":"P Kundu","year":"2016","unstructured":"Kundu P, et al. Delivery of dual drug loaded lipid based nanoparticles across the blood-brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease. ACS Chem Neurosci. 2016;7(12):1658\u201370.","journal-title":"ACS Chem Neurosci"},{"key":"4747_CR52","doi-asserted-by":"crossref","unstructured":"Monopoli, M.P., et al., Biomolecular coronas provide the biological identity of nanosized materials. Nano-enabled Med Appl, 2020: 205\u2013229.","DOI":"10.1201\/9780429399039-7"},{"key":"4747_CR53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biocel.2015.11.019","volume":"75","author":"V Mirshafiee","year":"2016","unstructured":"Mirshafiee V, et al. The importance of selecting a proper biological milieu for protein corona analysis in vitro: human plasma versus human serum. Int J Biochem Cell Biol. 2016;75:188\u201395.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"4747_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tibtech.2016.08.011","volume":"35","author":"G Caracciolo","year":"2017","unstructured":"Caracciolo G, Farokhzad OC, Mahmoudi M. Biological identity of nanoparticles in vivo: clinical implications of the protein corona. Trends Biotechnol. 2017;35(3):257\u201364.","journal-title":"Trends Biotechnol"},{"issue":"25","key":"4747_CR55","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1039\/c3cc37307j","volume":"49","author":"V Mirshafiee","year":"2013","unstructured":"Mirshafiee V, et al. Protein corona significantly reduces active targeting yield. Chem Commun. 2013;49(25):2557\u20139.","journal-title":"Chem Commun"},{"key":"4747_CR56","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biopha.2018.12.133","volume":"111","author":"M Saeedi","year":"2019","unstructured":"Saeedi M, et al. Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother. 2019;111:666\u201375.","journal-title":"Biomed Pharmacother"},{"key":"4747_CR57","doi-asserted-by":"publisher","first-page":"1263420","DOI":"10.3389\/fphys.2023.1263420","volume":"14","author":"AL Reed","year":"2023","unstructured":"Reed AL, et al. Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases. Front Physiol. 2023;14:1263420.","journal-title":"Front Physiol"},{"issue":"10","key":"4747_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017;6(10):92.","journal-title":"Foods"},{"issue":"7","key":"4747_CR59","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1039\/C1CS15233E","volume":"41","author":"CD Walkey","year":"2012","unstructured":"Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41(7):2780\u201399.","journal-title":"Chem Soc Rev"},{"key":"4747_CR60","first-page":"1","volume":"5","author":"ME Orr","year":"2013","unstructured":"Orr ME, Oddo S. Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2013;5:1\u20139.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"3","key":"4747_CR61","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.apsb.2022.01.008","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, et al. Impairment of the autophagy\u2013lysosomal pathway in Alzheimer\u2019s diseases: pathogenic mechanisms and therapeutic potential. Acta Pharmaceutica Sinica B. 2022;12(3):1019\u201340.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"4","key":"4747_CR62","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1021\/acsanm.3c04846","volume":"7","author":"N Pradhan","year":"2024","unstructured":"Pradhan N, Jana NR. Nanomodulators that target Alzheimer\u2019s disease: a review. ACS Appl Nano Mater. 2024;7(4):3515\u201345.","journal-title":"ACS Appl Nano Mater"},{"issue":"1","key":"4747_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-023-00362-0","volume":"12","author":"CH Lo","year":"2023","unstructured":"Lo CH, Zeng J. Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases. Transl Neurodegener. 2023;12(1):29.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"4747_CR64","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/15548627.2015.1136769","volume":"12","author":"M Bourdenx","year":"2016","unstructured":"Bourdenx M, et al. Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases. Autophagy. 2016;12(3):472\u201383.","journal-title":"Autophagy"},{"issue":"3","key":"4747_CR65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.nano.2009.11.007","volume":"6","author":"Z Yang","year":"2010","unstructured":"Yang Z, et al. Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine (Lond). 2010;6(3):427\u201341.","journal-title":"Nanomedicine (Lond)"},{"key":"4747_CR66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2019.12.034","volume":"319","author":"D Gopalan","year":"2020","unstructured":"Gopalan D, et al. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers. J Control Release. 2020;319:183\u2013200.","journal-title":"J Control Release"},{"issue":"3","key":"4747_CR67","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1039\/D4MH01256A","volume":"12","author":"M Bai","year":"2025","unstructured":"Bai M, et al. Application of carbon-based nanomaterials in Alzheimer\u2019s disease. Mater Horiz. 2025;12(3):673\u201393.","journal-title":"Mater Horiz"},{"issue":"1","key":"4747_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41390-021-01681-6","volume":"92","author":"G Cellot","year":"2022","unstructured":"Cellot G, FranceschiBiagioni A, Ballerini L. Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system. Pediatr Res. 2022;92(1):71\u20139.","journal-title":"Pediatr Res"},{"key":"4747_CR69","doi-asserted-by":"publisher","first-page":"1265347","DOI":"10.3389\/fonc.2023.1265347","volume":"13","author":"D Elsori","year":"2023","unstructured":"Elsori D, et al. Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer\u2019s disease and brain tumors. Front Oncol. 2023;13:1265347.","journal-title":"Front Oncol"},{"issue":"1","key":"4747_CR70","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/548389","volume":"2012","author":"X Li","year":"2012","unstructured":"Li X, et al. Biocompatibility and toxicity of nanoparticles and nanotubes. J Nanomater. 2012;2012(1):548389.","journal-title":"J Nanomater"},{"issue":"11","key":"4747_CR71","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1021\/cr500304f","volume":"115","author":"V Georgakilas","year":"2015","unstructured":"Georgakilas V, et al. Broad family of carbon nanoallotropes: classification, chemistry, and applications of fullerenes, carbon dots, nanotubes, graphene, nanodiamonds, and combined superstructures. Chem Rev. 2015;115(11):4744\u2013822.","journal-title":"Chem Rev"},{"key":"4747_CR72","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.actbio.2022.06.029","volume":"148","author":"W Wang","year":"2022","unstructured":"Wang W, et al. A multi-target theranostic nano-composite against Alzheimer\u2019s disease fabricated by conjugating carbon dots and triple-functionalized human serum albumin. Acta Biomater. 2022;148:298\u2013309.","journal-title":"Acta Biomater"},{"issue":"1","key":"4747_CR73","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/1673-5374.286965","volume":"16","author":"SD Hettiarachchi","year":"2021","unstructured":"Hettiarachchi SD, Leblanc RM. Dual targeting nano-approaches for Alzheimer\u2019s disease etiology. Neural Regen Res. 2021;16(1):119\u201320.","journal-title":"Neural Regen Res"},{"issue":"16","key":"4747_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202106342","volume":"18","author":"A Truskewycz","year":"2022","unstructured":"Truskewycz A, et al. Carbon dot therapeutic platforms: administration, distribution, metabolism, excretion, toxicity, and therapeutic potential. Small. 2022;18(16):e2106342.","journal-title":"Small"},{"issue":"3","key":"4747_CR75","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","volume":"24","author":"M-M Mesulam","year":"1999","unstructured":"Mesulam M-M. Neuroplasticity failure in Alzheimer\u2019s disease: bridging the gap between plaques and tangles. Neuron. 1999;24(3):521\u20139.","journal-title":"Neuron"},{"issue":"8","key":"4747_CR76","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1007\/s12035-019-1467-8","volume":"56","author":"B Bie","year":"2019","unstructured":"Bie B, et al. Activation of mGluR1 mediates C1q-dependent microglial phagocytosis of glutamatergic synapses in Alzheimer\u2019s rodent models. Mol Neurobiol. 2019;56(8):5568\u201385.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"4747_CR77","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559\u201369.","journal-title":"Glia"},{"issue":"3","key":"4747_CR78","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u201381.","journal-title":"Immunity"},{"issue":"3","key":"4747_CR79","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41380-023-02376-6","volume":"29","author":"S Lista","year":"2024","unstructured":"Lista S, et al. Monitoring synaptic pathology in Alzheimer\u2019s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives. Mol Psychiatry. 2024;29(3):847\u201357.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"4747_CR80","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4103\/NRR.NRR-D-24-01227","volume":"21","author":"R Ni","year":"2026","unstructured":"Ni R. Biomarkers for synaptic dysfunction in Alzheimer\u2019s disease. Neural Regen Res. 2026;21(2):683\u20134.","journal-title":"Neural Regen Res"},{"key":"4747_CR81","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","volume":"10","author":"G Cenini","year":"2019","unstructured":"Cenini G, Voos W. Mitochondria as potential targets in Alzheimer disease therapy: an update. Front Pharmacol. 2019;10:902.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4747_CR82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/wnan.1305","volume":"7","author":"RK Pathak","year":"2015","unstructured":"Pathak RK, Kolishetti N, Dhar S. Targeted nanoparticles in mitochondrial medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(3):315\u201329.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4747_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2021.101028","volume":"23","author":"S Song","year":"2021","unstructured":"Song S, et al. Emerging two-dimensional materials-enabled diagnosis and treatments of Alzheimer\u2019s disease: status and future challenges. Appl Mater Today. 2021;23:101028.","journal-title":"Appl Mater Today"},{"issue":"11","key":"4747_CR84","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1021\/cn4001582","volume":"4","author":"H Amiri","year":"2013","unstructured":"Amiri H, et al. Alzheimer\u2019s disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem Neurosci. 2013;4(11):1417\u201329.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"4747_CR85","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/NRR.NRR-D-24-01019","volume":"21","author":"I Jahan","year":"2026","unstructured":"Jahan I, et al. Neuronal plasticity and its role in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neural Regen Res. 2026;21(1):107\u201325.","journal-title":"Neural Regen Res"},{"issue":"3","key":"4747_CR86","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;62(3):1403\u201316.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"11","key":"4747_CR87","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1039\/C9NR09713A","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer\u2019s disease. Nanoscale. 2020;12(11):6498\u2013511.","journal-title":"Nanoscale"},{"issue":"9","key":"4747_CR88","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1074\/jbc.M117.811315","volume":"293","author":"S Hashimoto","year":"2018","unstructured":"Hashimoto S, et al. Endoplasmic reticulum stress responses in mouse models of Alzheimer\u2019s disease: overexpression paradigm versus knockin paradigm. J Biol Chem. 2018;293(9):3118\u201325.","journal-title":"J Biol Chem"},{"issue":"2","key":"4747_CR89","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acschemneuro.4c00770","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, et al. Visualizing endoplasmic reticulum stress and autophagy in Alzheimer\u2019s model cells by a peroxynitrite-responsive AIEgen fluorescent probe. ACS Chem Neurosci. 2025;16(2):223\u201331.","journal-title":"ACS Chem Neurosci"},{"key":"4747_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.212770","volume":"136","author":"Y Hao","year":"2022","unstructured":"Hao Y, et al. Bioengineered microglia-targeted exosomes facilitate A\u03b2 clearance via enhancing activity of microglial lysosome for promoting cognitive recovery in Alzheimer\u2019s disease. Biomaterials Advances. 2022;136:212770.","journal-title":"Biomaterials Advances"},{"issue":"2","key":"4747_CR91","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4103\/NRR.NRR-D-23-01736","volume":"20","author":"M Hao","year":"2025","unstructured":"Hao M, et al. Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer\u2019s disease. Neural Regen Res. 2025;20(2):424\u201339.","journal-title":"Neural Regen Res"},{"key":"4747_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/17435889.2025.2588421","author":"Y Gu","year":"2025","unstructured":"Gu Y, et al. Mesenchymal stem cell-derived nanovesicles coated PLGA nanoparticle (MSC-PLGA-NPs) remodel lysosomal function to clear pathological proteins in Alzheimer\u2019s disease models. Nanomedicine. 2025. https:\/\/doi.org\/10.1080\/17435889.2025.2588421.","journal-title":"Nanomedicine"},{"issue":"5","key":"4747_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202413614","volume":"37","author":"R Meng","year":"2025","unstructured":"Meng R, et al. Polyphenol mediated assembly: tailored nano-dredger unblocks axonal autophagosomes retrograde transport traffic jam for accelerated Alzheimer\u2019s waste clearance. Adv Mater. 2025;37(5):e2413614.","journal-title":"Adv Mater"},{"issue":"5","key":"4747_CR94","doi-asserted-by":"publisher","first-page":"2411061","DOI":"10.1002\/adma.202411061","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, et al. Lysosome-targeting protein degradation through endocytosis pathway triggered by polyvalent nano-chimera for AD therapy. Adv Mater. 2025;37(5):2411061.","journal-title":"Adv Mater"},{"issue":"33","key":"4747_CR95","doi-asserted-by":"publisher","first-page":"15079","DOI":"10.1021\/acs.iecr.9b02196","volume":"58","author":"ME Wechsler","year":"2019","unstructured":"Wechsler ME, Vela Ramirez JE, Peppas NA. 110th anniversary: nanoparticle mediated drug delivery for the treatment of Alzheimer\u2019s disease: crossing the blood\u2013brain barrier. Ind Eng Chem Res. 2019;58(33):15079\u201387.","journal-title":"Ind Eng Chem Res"},{"issue":"2\u20133","key":"4747_CR96","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","volume":"108","author":"C Roney","year":"2005","unstructured":"Roney C, et al. Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer\u2019s disease. J Control Release. 2005;108(2\u20133):193\u2013214.","journal-title":"J Control Release"},{"issue":"7","key":"4747_CR97","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/jcbfm.2012.25","volume":"32","author":"DB Stanimirovic","year":"2012","unstructured":"Stanimirovic DB, Friedman A. Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab. 2012;32(7):1207\u201321.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4747_CR98","doi-asserted-by":"publisher","first-page":"1510798","DOI":"10.3389\/fphar.2025.1510798","volume":"16","author":"J Jia","year":"2025","unstructured":"Jia J, et al. Engineered nanoparticles for the treatment of Alzheimer\u2019s disease. Front Pharmacol. 2025;16:1510798.","journal-title":"Front Pharmacol"},{"issue":"9","key":"4747_CR99","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/ijms22094661","volume":"22","author":"AB Salmina","year":"2021","unstructured":"Salmina AB, et al. Blood\u2013brain barrier and neurovascular unit in vitro models for studying mitochondria-driven molecular mechanisms of neurodegeneration. Int J Mol Sci. 2021;22(9):4661.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4747_CR100","doi-asserted-by":"publisher","first-page":"1600243","DOI":"10.1002\/biot.201600243","volume":"12","author":"HL Xu","year":"2017","unstructured":"Xu HL, et al. Delivery of growth factor-based therapeutics in vascular diseases: challenges and strategies. Biotechnol J. 2017;12(5):1600243.","journal-title":"Biotechnol J"},{"key":"4747_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114825","volume":"379","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Pericytes in Alzheimer\u2019s disease: key players and therapeutic targets. Exp Neurol. 2024;379:114825.","journal-title":"Exp Neurol"},{"key":"4747_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121904","volume":"291","author":"X Li","year":"2022","unstructured":"Li X, et al. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke. Biomaterials. 2022;291:121904.","journal-title":"Biomaterials"},{"key":"4747_CR103","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","volume":"93","author":"W Peng","year":"2016","unstructured":"Peng W, et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2016;93:215\u201325.","journal-title":"Neurobiol Dis"},{"issue":"20","key":"4747_CR104","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.3390\/molecules29204854","volume":"29","author":"Y Zhuo","year":"2024","unstructured":"Zhuo Y, Zhao Y-G, Zhang Y. Enhancing drug solubility, bioavailability, and targeted therapeutic applications through magnetic nanoparticles. Molecules. 2024;29(20):4854.","journal-title":"Molecules"},{"key":"4747_CR105","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","volume":"358","author":"J Liao","year":"2023","unstructured":"Liao J, et al. Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies. J Control Release. 2023;358:439\u201364.","journal-title":"J Control Release"},{"issue":"5","key":"4747_CR106","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1570159X23666241101093436","volume":"23","author":"T Nie","year":"2025","unstructured":"Nie T, et al. Microbiota-gut-brain axis in age-related neurodegenerative diseases. Curr Neuropharmacol. 2025;23(5):524\u201346.","journal-title":"Curr Neuropharmacol"},{"key":"4747_CR107","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2024.04.014","volume":"370","author":"L Kan","year":"2024","unstructured":"Kan L, et al. Recent progress on engineered micro\/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease. J Control Release. 2024;370:43\u201365.","journal-title":"J Control Release"},{"issue":"11","key":"4747_CR108","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s43587-023-00516-9","volume":"3","author":"X Guo","year":"2023","unstructured":"Guo X, et al. Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut\u2013brain axis. Nature Aging. 2023;3(11):1415\u201329.","journal-title":"Nature Aging"},{"key":"4747_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105520","volume":"104","author":"VA Uyanga","year":"2023","unstructured":"Uyanga VA, et al. Chitosan and chitosan-based composites as beneficial compounds for animal health: Impact on gastrointestinal functions and biocarrier application. Journal of Functional Foods. 2023;104:105520.","journal-title":"Journal of Functional Foods"},{"issue":"20","key":"4747_CR110","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3390\/molecules25204866","volume":"25","author":"E Manek","year":"2020","unstructured":"Manek E, Darvas F, Petroianu GA. Use of biodegradable, chitosan-based nanoparticles in the treatment of Alzheimer\u2019s disease. Molecules. 2020;25(20):4866.","journal-title":"Molecules"},{"issue":"8","key":"4747_CR111","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762.","journal-title":"Viruses"},{"key":"4747_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115577","volume":"167","author":"A Sun","year":"2023","unstructured":"Sun A, et al. Emerging nanotherapeutic strategies targeting gut-X axis against diseases. Biomed Pharmacother. 2023;167:115577.","journal-title":"Biomed Pharmacother"},{"issue":"47","key":"4747_CR113","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw5984","volume":"11","author":"W Liu","year":"2025","unstructured":"Liu W, et al. miRNA-loaded biomimetic nanoparticles orchestrate gut microbe to ameliorate inflammatory bowel disease. Sci Adv. 2025;11(47):eadw5984.","journal-title":"Sci Adv"},{"key":"4747_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124316","volume":"239","author":"L Yang","year":"2023","unstructured":"Yang L, et al. Resveratrol-loaded selenium\/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer\u2019s disease. Int J Biol Macromol. 2023;239:124316.","journal-title":"Int J Biol Macromol"},{"key":"4747_CR115","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.2147\/IJN.S374024","volume":"17","author":"L Qiao","year":"2022","unstructured":"Qiao L, et al. Selenium nanoparticles-enriched lactobacillus casei ATCC 393 prevents cognitive dysfunction in mice through modulating microbiota-gut-brain axis. Int J Nanomed. 2022;17:4807\u201327.","journal-title":"Int J Nanomed"},{"issue":"19","key":"4747_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38635","volume":"10","author":"C Fu","year":"2024","unstructured":"Fu C, et al. Exploring the mechanism of chondroitin sulfate-selenium nanoparticles in improving Alzheimer\u2019s disease: insights from intestinal flora evaluation. Heliyon. 2024;10(19):e38635.","journal-title":"Heliyon"},{"issue":"1","key":"4747_CR117","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acschemneuro.5c00637","volume":"17","author":"J Shin","year":"2026","unstructured":"Shin J, Kang HW, Kim S. Nanoscale structural and immunological remodeling of the primo vascular system in Alzheimer\u2019s disease: mast cell activation along the gut-brain axis. ACS Chem Neurosci. 2026;17(1):109\u201323.","journal-title":"ACS Chem Neurosci"},{"issue":"12","key":"4747_CR118","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1002\/alz.12567","volume":"18","author":"BN Vardarajan","year":"2022","unstructured":"Vardarajan BN, et al. Progranulin mutations in clinical and neuropathological Alzheimer\u2019s disease. Alzheimers Dement. 2022;18(12):2458\u201367.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"4747_CR119","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s12035-024-04343-w","volume":"62","author":"AV Skalny","year":"2025","unstructured":"Skalny AV, et al. The role of gut microbiota in the neuroprotective effects of selenium in Alzheimer\u2019s disease. Mol Neurobiol. 2025;62(2):1675\u201392.","journal-title":"Mol Neurobiol"},{"key":"4747_CR120","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fgene.2018.00579","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Jiao B, Shen L. The epigenetics of Alzheimer\u2019s disease: factors and therapeutic implications. Front Genet. 2018;9:579.","journal-title":"Front Genet"},{"issue":"2","key":"4747_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12031-025-02363-2","volume":"75","author":"P Tiwari","year":"2025","unstructured":"Tiwari P, et al. Genetics and epigenetics of Alzheimer\u2019s disease: understanding pathogenesis and exploring therapeutic potential. J Mol Neurosci. 2025;75(2):1\u201315.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"4747_CR122","doi-asserted-by":"publisher","first-page":"21","DOI":"10.33696\/Psychiatry.3.023","volume":"3","author":"M Ye","year":"2025","unstructured":"Ye M, et al. Epigenetic regulation in Alzheimer\u2019s disease-development, challenges, and future perspectives. Arch Psychiatry. 2025;3(1):21\u20135.","journal-title":"Arch Psychiatry"},{"issue":"12","key":"4747_CR123","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1021\/nn9012274","volume":"3","author":"Z Wang","year":"2009","unstructured":"Wang Z, et al. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano. 2009;3(12):4110\u20136.","journal-title":"ACS Nano"},{"issue":"1","key":"4747_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-025-03528-2","volume":"23","author":"N Sanadgol","year":"2025","unstructured":"Sanadgol N, et al. Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges. J Nanobiotechnol. 2025;23(1):1\u201328.","journal-title":"J Nanobiotechnol"},{"key":"4747_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100040","volume":"6","author":"C De Souza","year":"2020","unstructured":"De Souza C, et al. Nanomaterials as potential transporters of HDAC inhibitors. Med Drug Discov. 2020;6:100040.","journal-title":"Med Drug Discov"},{"issue":"2","key":"4747_CR126","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10895-016-1988-8","volume":"27","author":"S Delkhahi","year":"2017","unstructured":"Delkhahi S, Rahaie M, Rahimi F. Design and fabrication a gold nanoparticle-DNA based nanobiosensor for detection of microRNA Involved in Alzheimer\u2019s disease. J Fluoresc. 2017;27(2):603\u201310.","journal-title":"J Fluoresc"},{"key":"4747_CR127","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-443-13205-6.00012-1","volume-title":"Alzheimer\u2019s disease and advanced drug delivery strategies","author":"S Rawal","year":"2024","unstructured":"Rawal S, Khodakiya A, Prajapati BG. Chapter 9 - Nanotechnology-based delivery for CRISPR-Cas 9 cargo in Alzheimer\u2019s disease. In: Prajapati BG, Chellappan DK, Kendre PN, editors. Alzheimer\u2019s disease and advanced drug delivery strategies. Academic Press; 2024. p. 139\u201352."},{"issue":"32","key":"4747_CR128","doi-asserted-by":"publisher","first-page":"9906","DOI":"10.1021\/acs.nanolett.4c02272","volume":"24","author":"J Yang","year":"2024","unstructured":"Yang J, et al. A Nanozyme-boosted MOF-CRISPR platform for treatment of Alzheimer\u2019s disease. Nano Lett. 2024;24(32):9906\u201315.","journal-title":"Nano Lett"},{"issue":"2","key":"4747_CR129","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"SG Patching","year":"2017","unstructured":"Patching SG. Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol. 2017;54(2):1046\u201377.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"4747_CR130","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148\u201360.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"4747_CR131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci. 2008;1147(1):180\u201395.","journal-title":"Ann N Y Acad Sci"},{"key":"4747_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105158","volume":"150","author":"T Khan","year":"2021","unstructured":"Khan T, et al. Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice. Neurochem Int. 2021;150:105158.","journal-title":"Neurochem Int"},{"issue":"5","key":"4747_CR133","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, et al. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74(5):557\u201366.","journal-title":"JAMA Neurol"},{"issue":"10","key":"4747_CR134","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.15252\/emmm.201606540","volume":"8","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, et al. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease. EMBO Mol Med. 2016;8(10):1184\u201396.","journal-title":"EMBO Mol Med"},{"key":"4747_CR135","doi-asserted-by":"publisher","first-page":"117727192095031","DOI":"10.1177\/1177271920950319","volume":"15","author":"E Camporesi","year":"2020","unstructured":"Camporesi E, et al. Fluid biomarkers for synaptic dysfunction and loss. Biomark Insights. 2020;15:1177271920950319.","journal-title":"Biomark Insights"},{"issue":"12","key":"4747_CR136","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/brain\/awaa325","volume":"143","author":"BM Tijms","year":"2020","unstructured":"Tijms BM, et al. Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics. Brain. 2020;143(12):3776\u201392.","journal-title":"Brain"},{"issue":"11","key":"4747_CR137","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s43587-022-00300-1","volume":"2","author":"M Del Campo","year":"2022","unstructured":"Del Campo M, et al. CSF proteome profiling across the Alzheimer\u2019s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature aging. 2022;2(11):1040\u201353.","journal-title":"Nature aging"},{"issue":"11","key":"4747_CR138","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1161\/ATVBAHA.119.313099","volume":"39","author":"MM Mielke","year":"2019","unstructured":"Mielke MM, et al. Elevated plasma ceramides are associated with higher white matter hyperintensity volume\u2014brief report. Arterioscler Thromb Vasc Biol. 2019;39(11):2431\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"4747_CR139","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s12276-020-0418-9","volume":"52","author":"SA Park","year":"2020","unstructured":"Park SA, Han SM, Kim CE. New fluid biomarkers tracking non-amyloid-\u03b2 and non-tau pathology in Alzheimer\u2019s disease. Exp Mol Med. 2020;52(4):556\u201368.","journal-title":"Exp Mol Med"},{"issue":"3","key":"4747_CR140","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer\u2019s disease. Nat Immunol. 2015;16(3):229\u201336.","journal-title":"Nat Immunol"},{"issue":"1","key":"4747_CR141","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-023-00393-7","volume":"13","author":"HM Gebril","year":"2024","unstructured":"Gebril HM, et al. Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer\u2019s pathology. Transl Neurodegener. 2024;13(1):2.","journal-title":"Transl Neurodegener"},{"issue":"8","key":"4747_CR142","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8):983\u201397.","journal-title":"Nat Med"},{"key":"4747_CR143","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-2094-6-41","volume":"6","author":"A Salminen","year":"2009","unstructured":"Salminen A, et al. ER stress in Alzheimer\u2019s disease: a novel neuronal trigger for inflammation and Alzheimer\u2019s pathology. J Neuroinflammation. 2009;6:41.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"4747_CR144","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1007\/s12035-020-01929-y","volume":"57","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, et al. Molecular mechanisms of ER stress and UPR in the pathogenesis of Alzheimer\u2019s disease. Mol Neurobiol. 2020;57(7):2902\u201319.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4747_CR145","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12951-024-02543-z","volume":"22","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. A\u03b2(42) and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer\u2019s disease. J Nanobiotechnol. 2024;22(1):278.","journal-title":"J Nanobiotechnol"},{"key":"4747_CR146","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fphar.2019.00778","volume":"10","author":"D Mango","year":"2019","unstructured":"Mango D, et al. Targeting synaptic plasticity in experimental models of Alzheimer\u2019s disease. Front Pharmacol. 2019;10:778.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4747_CR147","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133\u201350.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"4747_CR148","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877\u20132013.","journal-title":"Physiol Rev"},{"key":"4747_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202500006","author":"ZS Hoseini","year":"2025","unstructured":"Hoseini ZS, et al. Nanoparticles and their impact on epigenetic mechanisms: insights and implications. Adv Ther (Weinh). 2025. https:\/\/doi.org\/10.1002\/adtp.202500006.","journal-title":"Adv Ther (Weinh)"},{"issue":"13","key":"4747_CR150","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.7150\/thno.98473","volume":"14","author":"A Almahmoud","year":"2024","unstructured":"Almahmoud A, et al. Intranasal delivery of imaging agents to the brain. Theranostics. 2024;14(13):5022.","journal-title":"Theranostics"},{"issue":"6","key":"4747_CR151","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1039\/D5PM00148J","volume":"2","author":"H Li","year":"2025","unstructured":"Li H, et al. Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer\u2019s disease treatment. RSC Pharmaceutics. 2025;2(6):1323\u201348.","journal-title":"RSC Pharmaceutics"},{"issue":"1","key":"4747_CR152","first-page":"20","volume":"15","author":"F Alavian","year":"2020","unstructured":"Alavian F, Shams N. Oral and Intra-nasal administration of nanoparticles in the cerebral ischemia treatment in animal experiments: considering its advantages and disadvantages. Curr Clin Pharmacol. 2020;15(1):20\u20139.","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"4747_CR153","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/antiox13030303","volume":"13","author":"HR Modi","year":"2024","unstructured":"Modi HR, et al. Mitochondria-targeted antioxidant therapeutics for traumatic brain injury. Antioxidants. 2024;13(3):303.","journal-title":"Antioxidants"},{"issue":"1","key":"4747_CR154","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12967-024-04908-2","volume":"22","author":"JD Pandya","year":"2024","unstructured":"Pandya JD, et al. Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties. J Transl Med. 2024;22(1):167.","journal-title":"J Transl Med"},{"issue":"6","key":"4747_CR155","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/pharmaceutics16060746","volume":"16","author":"H Omidian","year":"2024","unstructured":"Omidian H, et al. Chitosan nanoparticles for intranasal drug delivery. Pharmaceutics. 2024;16(6):746.","journal-title":"Pharmaceutics"},{"key":"4747_CR156","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.msec.2017.05.110","volume":"79","author":"GK Ferreira","year":"2017","unstructured":"Ferreira GK, et al. Effect of acute and long-term administration of gold nanoparticles on biochemical parameters in rat brain. Mater Sci Eng C Mater Biol Appl. 2017;79:748\u201355.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"5","key":"4747_CR157","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1021\/nn901869f","volume":"4","author":"E Hutter","year":"2010","unstructured":"Hutter E, et al. Microglial response to gold nanoparticles. ACS Nano. 2010;4(5):2595\u2013606.","journal-title":"ACS Nano"},{"issue":"5","key":"4747_CR158","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/17435889.3.5.703","volume":"3","author":"M Longmire","year":"2008","unstructured":"Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine. 2008;3(5):703\u201317.","journal-title":"Nanomedicine"},{"issue":"1","key":"4747_CR159","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-8977-9-20","volume":"9","author":"ST Stern","year":"2012","unstructured":"Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 2012;9(1):20.","journal-title":"Part Fibre Toxicol"},{"issue":"5","key":"4747_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005491","volume":"4","author":"A Petit-Paitel","year":"2009","unstructured":"Petit-Paitel A, et al. Involvment of cytosolic and mitochondrial GSK-3\u03b2 in mitochondrial dysfunction and neuronal cell death of MPTP\/MPP+-treated neurons. PLoS ONE. 2009;4(5):e5491.","journal-title":"PLoS ONE"},{"issue":"7","key":"4747_CR161","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/14737175.2017.1326818","volume":"17","author":"A Khan","year":"2017","unstructured":"Khan A, Corbett A, Ballard C. Emerging treatments for Alzheimer\u2019s disease for non-amyloid and non-tau targets. Expert Rev Neurother. 2017;17(7):683\u201395.","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"4747_CR162","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, et al. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602\u201363.","journal-title":"Chem Rev"},{"issue":"7","key":"4747_CR163","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1039\/C6TB03066A","volume":"5","author":"J Zhu","year":"2017","unstructured":"Zhu J, et al. Stimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challenges. J Mater Chem B. 2017;5(7):1339\u201352.","journal-title":"J Mater Chem B"},{"issue":"14","key":"4747_CR164","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1039\/D5NR00107B","volume":"17","author":"L Qiu","year":"2025","unstructured":"Qiu L, et al. Manganese-based nanoenzymes: from catalytic chemistry to design principle and antitumor\/antibacterial therapy. Nanoscale. 2025;17(14):8301\u201315.","journal-title":"Nanoscale"},{"issue":"5","key":"4747_CR165","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1021\/acsbiomaterials.3c01852","volume":"10","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Zhao J, Zhang D. Manganese dioxide-based nanomaterials for medical applications. ACS Biomater Sci Eng. 2024;10(5):2680\u2013702.","journal-title":"ACS Biomater Sci Eng"},{"issue":"11","key":"4747_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13113098","volume":"13","author":"G Tondo","year":"2024","unstructured":"Tondo G, et al. Novel therapeutic strategies in Alzheimer\u2019s disease: pitfalls and challenges of anti-amyloid therapies and beyond. J Clin Med. 2024;13(11):3098.","journal-title":"J Clin Med"},{"key":"4747_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114426","volume":"389","author":"G Wang","year":"2026","unstructured":"Wang G, et al. Clinical translation of nanomedicines for brain diseases: Current challenges and future directions. J Control Release. 2026;389:114426.","journal-title":"J Control Release"},{"issue":"10","key":"4747_CR168","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression. Cell Res. 2019;29(10):787\u2013803.","journal-title":"Cell Res"},{"issue":"1","key":"4747_CR169","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","volume":"13","author":"S Xiao","year":"2021","unstructured":"Xiao S, et al. A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer\u2019s dementia. Alzheimers Res Ther. 2021;13(1):62.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"4747_CR170","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/ars.2020.8070","volume":"34","author":"Y Mi","year":"2021","unstructured":"Mi Y, et al. Mitochondria-targeted therapeutics for Alzheimer\u2019s Disease: the good, the bad, the potential. Antioxid Redox Signal. 2021;34(8):611\u201330.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"4747_CR171","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1080\/15548627.2022.2110729","volume":"18","author":"J-H Lee","year":"2022","unstructured":"Lee J-H, Nixon RA. Autolysosomal acidification failure as a primary driver of Alzheimer disease pathogenesis. Autophagy. 2022;18(11):2763\u20134.","journal-title":"Autophagy"},{"key":"4747_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102318","volume":"98","author":"F Mazahir","year":"2024","unstructured":"Mazahir F, Alam MI, Yadav AK. Development of nanomedicines for the treatment of Alzheimer\u2019s disease: Raison d\u2019etre, strategies, challenges and regulatory aspects. Ageing Res Rev. 2024;98:102318.","journal-title":"Ageing Res Rev"},{"key":"4747_CR173","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1201\/9781003220602-7","volume-title":"Nanomanufacturing and Nanomaterials Design","author":"F Ahmad","year":"2022","unstructured":"Ahmad F, Ogra A, Ahmad S. Nanomanufacturing of Biomedicines: Current Status and Future Challenges. In: Nanomanufacturing and Nanomaterials Design. CRC Press; 2022. p. 95\u2013136."},{"issue":"2","key":"4747_CR174","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/separations10020109","volume":"10","author":"F Foret","year":"2023","unstructured":"Foret F, et al. Proceedings of APCE-CECE-ITP-IUPAC 2022. Separations. 2023;10(2):109.","journal-title":"Separations"},{"issue":"15","key":"4747_CR175","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, et al. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688\u2013713.","journal-title":"Adv Drug Deliv Rev"},{"key":"4747_CR176","doi-asserted-by":"publisher","first-page":"1544393","DOI":"10.3389\/fmed.2025.1544393","volume":"12","author":"FD Rodr\u00edguez-G\u00f3mez","year":"2025","unstructured":"Rodr\u00edguez-G\u00f3mez FD, et al. Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Front Med. 2025;12:1544393.","journal-title":"Front Med"},{"issue":"3","key":"4747_CR177","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/13872877251346890","volume":"106","author":"T Alkam","year":"2025","unstructured":"Alkam T, Tarshizi E, Van Benschoten AH. Large language models for Alzheimer\u2019s disease drug discovery. J Alzheimers Dis. 2025;106(3):799\u2013822.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"4747_CR178","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","volume":"8","author":"J Cummings","year":"2016","unstructured":"Cummings J, et al. Drug development in Alzheimer\u2019s disease: the path to 2025. Alzheimer\u2019s Res Ther. 2016;8(1):39.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"11","key":"4747_CR179","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10856-023-06753-z","volume":"34","author":"K Wang","year":"2023","unstructured":"Wang K, et al. Long-term application of silver nanoparticles in dental restoration materials: potential toxic injury to the CNS. J Mater Sci Mater Med. 2023;34(11):52.","journal-title":"J Mater Sci Mater Med"},{"issue":"2","key":"4747_CR180","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai N. Challenges in development of nanoparticle-based therapeutics. Aaps j. 2012;14(2):282\u201395.","journal-title":"Aaps j"},{"issue":"4","key":"4747_CR181","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/ja2084338","volume":"134","author":"CD Walkey","year":"2012","unstructured":"Walkey CD, et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134(4):2139\u201347.","journal-title":"J Am Chem Soc"},{"key":"4747_CR182","doi-asserted-by":"crossref","unstructured":"Cho, H., et al. Conditional Diffusion with Ordinal Regression: Longitudinal Data Generation for Neurodegenerative Disease Studies. In The Thirteenth International Conference on Learning Representations. 2025.","DOI":"10.1002\/alz70855_096933"},{"key":"4747_CR183","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.colsurfb.2017.11.023","volume":"161","author":"F Aliakbari","year":"2018","unstructured":"Aliakbari F, et al. Formulation and anti-neurotoxic activity of baicalein-incorporating neutral nanoliposome. Colloids Surf, B. 2018;161:578\u201387.","journal-title":"Colloids Surf, B"},{"key":"4747_CR184","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jinorgbio.2016.04.017","volume":"163","author":"E Halevas","year":"2016","unstructured":"Halevas E, Nday C, Salifoglou A. Hybrid catechin silica nanoparticle influence on Cu (II) toxicity and morphological lesions in primary neuronal cells. J Inorg Biochem. 2016;163:240\u20139.","journal-title":"J Inorg Biochem"},{"key":"4747_CR185","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jinorgbio.2015.01.001","volume":"145","author":"CM Nday","year":"2015","unstructured":"Nday CM, et al. Quercetin encapsulation in modified silica nanoparticles: potential use against Cu (II)-induced oxidative stress in neurodegeneration. J Inorg Biochem. 2015;145:51\u201364.","journal-title":"J Inorg Biochem"},{"issue":"2","key":"4747_CR186","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2012-112141","volume":"30","author":"S Doggui","year":"2012","unstructured":"Doggui S, et al. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J Alzheimers Dis. 2012;30(2):377\u201392.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"4747_CR187","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.2042-7158.2010.01225.x","volume":"63","author":"S Dhawan","year":"2011","unstructured":"Dhawan S, Kapil R, Singh B. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J Pharm Pharmacol. 2011;63(3):342\u201351.","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20132","key":"4747_CR188","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijpharm.2016.10.024","volume":"515","author":"P Kumar","year":"2016","unstructured":"Kumar P, et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences. Int J Pharm. 2016;515(1\u20132):307\u201314.","journal-title":"Int J Pharm"},{"issue":"1","key":"4747_CR189","first-page":"57","volume":"517","author":"LCGEI Moreno","year":"2017","unstructured":"Moreno LCGEI, et al. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int J Pharm. 2017;517(1):57\u201350.","journal-title":"Int J Pharm"},{"key":"4747_CR190","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s132472","author":"Y-C Kuo","year":"2017","unstructured":"Kuo Y-C, Tsao C-W. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7-and lactoferrin-grafted liposomes carrying quercetin. Int J Nanomedicine. 2017. https:\/\/doi.org\/10.2147\/ijn.s132472.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"4747_CR191","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jphp.12836","volume":"70","author":"LR Wong","year":"2018","unstructured":"Wong LR, Ho PC. Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer\u2019s disease. J Pharm Pharmacol. 2018;70(1):59\u201369.","journal-title":"J Pharm Pharmacol"},{"key":"4747_CR192","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.msec.2017.03.283","volume":"77","author":"AP Muller","year":"2017","unstructured":"Muller AP, et al. Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer\u2019s type. Mater Sci Eng C Mater Biol Appl. 2017;77:476\u201383.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"4747_CR193","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuint.2017.08.001","volume":"112","author":"A Yadav","year":"2018","unstructured":"Yadav A, et al. Resveratrol loaded solid lipid nanoparticles attenuate mitochondrial oxidative stress in vascular dementia by activating Nrf2\/HO-1 pathway. Neurochem Int. 2018;112:239\u201354.","journal-title":"Neurochem Int"},{"key":"4747_CR194","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.biomaterials.2019.01.037","volume":"197","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer\u2019s disease. Biomaterials. 2019;197:393\u2013404.","journal-title":"Biomaterials"},{"issue":"2","key":"4747_CR195","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s12035-019-01780-w","volume":"57","author":"N dos Santos Tramontin","year":"2020","unstructured":"dos Santos Tramontin N, et al. Gold nanoparticles treatment reverses brain damage in Alzheimer\u2019s disease model. Mol Neurobiol. 2020;57(2):926\u201336.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"4747_CR196","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/antiox10071003","volume":"10","author":"L Babylon","year":"2021","unstructured":"Babylon L, et al. Hesperetin nanocrystals improve mitochondrial function in a cell model of early Alzheimer disease. Antioxidants. 2021;10(7):1003.","journal-title":"Antioxidants"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04747-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04747-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04747-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:03:12Z","timestamp":1781798592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04747-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":196,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4747"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04747-8","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript presents a comprehensive literature review that synthesizes and critically analyzes previously published research on the use of nanoparticles for AD therapy. No original experimental research involving human participants, animals, or biological specimens was conducted by the authors. Therefore, ethical approval from an institutional review board or ethics committee was not required for this work. As this study exclusively involved the analysis of existing published literature without the collection of new data from human subjects, no informed consent to participate was necessary or obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This review contains no personally identifiable information, individual patient data, or images requiring specific consent for publication. All the content represents the authors\u2019 scholarly synthesis of publicly available scientific literature and original conceptual illustrations created for this manuscript. No third-party copyrighted material has been reproduced without appropriate attribution or licensing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}